Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Monitoring Sickle Cell Disease Using Spectral-Domain Optic Coherence Tomography in Pediatric Patients

Jing Jin, MD PhD, Robin E Miller, MD

Blood (2019) 134 (Supplement_1): 994.

https://doi.org/10.1182/blood-2019-123138

Published: 2019

Journal Articles

Ophthalmic Manifestations of Chronic Myeloid Leukemia As Initial Presentation and Unmet Needs

Shehab Mohamed, MD, Abdulqadir Jeprel Nashwan, BSN, MSN, RN, CBT-HMS, Ahmed Qatami, Mohamed A Yassin, MBBS, MSc

Blood (2018) 132 (Supplement 1): 5454.

https://doi.org/10.1182/blood-2018-99-115731

Published: 2018

Journal Articles

Evaluation of Ocular Complications By Using Optical Coherence Tomography in Children with Sickle Cell Disease

Esra Vatansever, MD, Mustafa Vatansever, MD, Erdem Dinç, MD, Gulhan Temel, MD, Selma Unal, MD

Blood (2018) 132 (Supplement 1): 2379.

https://doi.org/10.1182/blood-2018-99-116082

Published: 2018

Journal Articles

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

Tom Adamkiewicz, MD FRCPC, MSc, Peter Baltrus, PhD, Chaohua Li, MPH, Kitty Carter-Wicker, MD, Anne Gaglioti, MD

Blood (2018) 132 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2018-99-120132

Published: 2018

Journal Articles

Clinical Manifestations and Prognostic Factors of Chronic Ocular Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Lan Y Wang, MD, Gloria B Chiu, OD, FAAO, FSLS, Rachel A Young, OD, Mojtaba Akhtari, MD

Blood (2018) 132 (Supplement 1): 5731.

https://doi.org/10.1182/blood-2018-99-119903

Published: 2018

Journal Articles

Novel Hermanksky-Pudlak Syndrome Type 6 Missense Variant Associated with Subclinical Oculocutaneous Albinism and Mild Bleeding

Nagabhishek Moka, MD, Dong Chen, MD PhD, Chen Han, Kevin J O'Brien, ANP, Sara Haroutinian, Laryssa Huryn, Wendy Introne, MD, Ellen Macnamara, William A. Gahl, MD PhD, May Christine Malicdan, Bernadette Gochuico, MD, Koyamangalath Krishnan, MD

Blood (2018) 132 (Supplement 1): 1153.

https://doi.org/10.1182/blood-2018-99-109829

Published: 2018

Journal Articles

Occurrence and Management of Cataracts in Adult Patients (pts) with Chronic Immune Thrombocytopenia (cITP) during Long-Term Treatment with Eltrombopag (EPAG): Results from the Extend Study

Raymond SM Wong, MRCP,FRCP, Abderrahim Khelif, Abdulgabar Salama, Mansoor N. Saleh, Ozlem Ocak Arikan, Erhard Quebe-Fehling, PhD, James B. Bussel, MD

Blood (2017) 130 (Supplement 1): 1053.

https://doi.org/10.1182/blood.V130.Suppl_1.1053.1053

Published: 2017

Journal Articles

A Systematic Review and Meta-Analysis of the Effect of Iron Chelation Therapy on Survival in Patients with Lower Risk Myelodysplastic Syndrome

Smith Giri, MBBS, Samir K. Ballas, MD, Michelle Deveaux, Vu H. Duong, MD, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 3734.

https://doi.org/10.1182/blood.V130.Suppl_1.3734.3734

Published: 2017

Journal Articles

Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network

Choquet Sylvain, Marine Baron, Anne Lavaud, Carole Soussain, MD PhD, Valerie Touitou, MD PhD, Christine Fardeau, Nathalie Cassoux, MD PhD, Magali Le Garff-Tavernier, Mirto Costopoulos, Caroline Houillier, MD, Karim Maloum, Véronique Leblond, Emmanuel Gyan, MDPhD, Pierre Soubeyran, MD PhD

Blood (2017) 130 (Supplement 1): 2845.

https://doi.org/10.1182/blood.V130.Suppl_1.2845.2845

Published: 2017

Journal Articles

MM-013 Phase 2, Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): Pharmacokinetics (PK) Analysis

Pieter Sonneveld, MDPhD, Katja C. Weisel, Yan Li, Elisabeth Kueenburg, Shona Collins, Antonia Di Micco, Barbara Rosettani, Pamela Bacon, Meletios A. Dimopoulos

Blood (2017) 130 (Supplement 1): 1847.

https://doi.org/10.1182/blood.V130.Suppl_1.1847.1847

Published: 2017

Journal Articles

Development of a Novel, Portable Cost-Effective Sickle Cell Disease Diagnostic Test Suitable for Neonatal Screening in Low Resource Countries

Michael Ryan Cleary, Tej Vaddi

Blood (2016) 128 (22): 4844.

https://doi.org/10.1182/blood.V128.22.4844.4844

Published: 2016

Journal Articles

Transient Protein C Deficiency in an Infant with Factor V Leiden Heterozygous Mutation: a Rare Subgroup of Neonatal Purpura Fulminans

Sagar Pathak, DO, Natalie L. Kamberos, DO

Blood (2016) 128 (22): 4985.

https://doi.org/10.1182/blood.V128.22.4985.4985

Published: 2016

Journal Articles

Predictive Value of Minimal Residual Disease in WHO2016-Defined Mixed Phenotype Acute Leukemia (MPAL)

Etan Orgel, MD MS, Matthew Oberley, MD PhD, Sisi Li, MD, Jemily Malvar, MS, Maurice O'Gorman, PhD

Blood (2016) 128 (22): 178.

https://doi.org/10.1182/blood.V128.22.178.178

Published: 2016

Journal Articles

High Efficiency and Tolerance of Temozolomide in Relapse/Refractory Primary Intra-Ocular Lymphoma (R/R PIOL). a Retrospective Multicentric Study from the LOC Network

Marine Baron, Emmanuel Gyan, MD PhD, Hélène Merle-Beral, MD PhD, Veronique Leblond, MD PhD, Nathalie Cassoux, Valerie Touitou, Bahram Bodaghi, Adil Darugar, Sylvain Choquet, MD

Blood (2014) 124 (21): 3080.

https://doi.org/10.1182/blood.V124.21.3080.3080

Published: 2014

Journal Articles

BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion

Blood (2014) 124 (21): 3295.

https://doi.org/10.1182/blood.V124.21.3295.3295

Published: 2014

Journal Articles

Safety and Efficacy Of Eltrombopag At Escalated Doses Up To 150mg In Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive To 75 Mg

Catherine E. McGuinn, MD, Allison Imahiyerobo, ANP- BC, Micha Thompson, B.A., Naznin Haq, B.A., Claudia Tchatchouang, M.A., James B Bussel, MD

Blood (2013) 122 (21): 3559.

https://doi.org/10.1182/blood.V122.21.3559.3559

Published: 2013

Journal Articles

Myeloid Sarcoma of the Orbit and Ocular Adnexae

Maro Ohanian, DO, Mona Lisa Alattar, MD, Zeev Estrov, MD, PhD, Alfonso Quintas-Cardama, MD, John T Manning, MD, Farhad Ravandi, MD, Lynne V. Abruzzo, MD, PhD, Jorge E. Cortes, MD, Naveen Pemmaraju, M.D.

Blood (2012) 120 (21): 1463.

https://doi.org/10.1182/blood.V120.21.1463.1463

Published: 2012

Journal Articles

Final Results of a Multicenter Phase II Trial with Translational Elements to Investigate the Possible Infective Causes of Ocular Adnexal Marginal Zone B-Cell Lymphoma (OAMZL) with Particular Reference to Chlamydia Species and the Efficacy of Doxycycline As First-Line Lymphoma Treatment (the IELSG#27 TRIAL)

Silvia Govi, MD, Riccardo Dolcetti, MD, Maurilio Ponzoni, MD, Elisa Pasini, RF, Silvia Mappa, MD, Marta Bruno Ventre, MD, Claudio Doglioni, MD, Francesco Bertoni, MD, Francesco Zaja, MD, Carlos Montalban, MD, PhD, Caterina Stelitano, MD, Maria Elena Cabrera, MD, Franco Cavalli, MD, Emanuele Zucca, MD, Andrés J.M. Ferreri, MD

Blood (2011) 118 (21): 267.

https://doi.org/10.1182/blood.V118.21.267.267

Published: 2011

Journal Articles

Rate of Cataracts Across the Eltrombopag Clinical Studies in Patients with Chronic Immune Thrombocytopenia

Nichola Cooper, MRCP, MRCPath, MD, Raymond Wong, Andres Brainsky, MD, Christine K Bailey, PhD

Blood (2011) 118 (21): 1164.

https://doi.org/10.1182/blood.V118.21.1164.1164

Published: 2011

Journal Articles

Safety of Baxter’s Longer Acting rFVIII (BAX 855) After Repeated Application in Rats and Cynomolgus Monkeys

Barbara Dietrich, DVM, Margit Spatzenegger, PhD, Reinhard Stidl, PhD, Martin Wolfsegger, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch

Blood (2011) 118 (21): 4345.

https://doi.org/10.1182/blood.V118.21.4345.4345

Published: 2011

NARROW

Monitoring Sickle Cell Disease Using Spectral-Domain Optic Coherence Tomography in Pediatric Patients

Ophthalmic Manifestations of Chronic Myeloid Leukemia As Initial Presentation and Unmet Needs

Evaluation of Ocular Complications By Using Optical Coherence Tomography in Children with Sickle Cell Disease

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

Clinical Manifestations and Prognostic Factors of Chronic Ocular Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Novel Hermanksky-Pudlak Syndrome Type 6 Missense Variant Associated with Subclinical Oculocutaneous Albinism and Mild Bleeding

Occurrence and Management of Cataracts in Adult Patients (pts) with Chronic Immune Thrombocytopenia (cITP) during Long-Term Treatment with Eltrombopag (EPAG): Results from the Extend Study

A Systematic Review and Meta-Analysis of the Effect of Iron Chelation Therapy on Survival in Patients with Lower Risk Myelodysplastic Syndrome

Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network

MM-013 Phase 2, Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): Pharmacokinetics (PK) Analysis

Development of a Novel, Portable Cost-Effective Sickle Cell Disease Diagnostic Test Suitable for Neonatal Screening in Low Resource Countries

Transient Protein C Deficiency in an Infant with Factor V Leiden Heterozygous Mutation: a Rare Subgroup of Neonatal Purpura Fulminans

Predictive Value of Minimal Residual Disease in WHO2016-Defined Mixed Phenotype Acute Leukemia (MPAL)

High Efficiency and Tolerance of Temozolomide in Relapse/Refractory Primary Intra-Ocular Lymphoma (R/R PIOL). a Retrospective Multicentric Study from the LOC Network

BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion

Safety and Efficacy Of Eltrombopag At Escalated Doses Up To 150mg In Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive To 75 Mg

Myeloid Sarcoma of the Orbit and Ocular Adnexae

Rate of Cataracts Across the Eltrombopag Clinical Studies in Patients with Chronic Immune Thrombocytopenia

Safety of Baxter’s Longer Acting rFVIII (BAX 855) After Repeated Application in Rats and Cynomolgus Monkeys

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only